Accessing the inaccessible
Reimagining small molecule drug discovery by harnessing AI to unlock the vastness of chemical space and deliver more effective therapies
Unlocking novel chemical spaces through AI-enabled drug discovery.
Drugging challenging targets inaccessible with traditional small molecules drug discovery.
Unleashing therapeutic differentiation through innovative first- and best-in-class drugs.
Overcoming the chemical space bottlenecks to develop life changing medicines for challenging and data-sparse targets
Explore our rapidly growing pipeline.
Meet our world-class team
We are a spin-out based on ground-breaking research from the University of Cambridge, UK
Supported by:
